» Articles » PMID: 27473047

The Impact of Socioeconomic Factors on the Efficiency of Voluntary Toxoplasmosis Screening During Pregnancy: a Population-based Study

Overview
Publisher Biomed Central
Date 2016 Jul 31
PMID 27473047
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Congenital toxoplasmosis is associated with severe complications. German state health insurance covers rubella, but not toxoplasmosis, immunity screening. We analysed the effect of socioeconomic factors on the efficiency of private toxoplasmosis screening during pregnancy.

Methods: Toxoplasmosis and rubella screening data (n = 5402 mothers) were collected within the population-based Survey of Neonates in Pomerania (SNiP).

Results: At the first-trimester screening, 34.4 % (88.1 %) of expecting mothers were immune to toxoplasmosis (rubella). Susceptibility for toxoplasmosis (rubella) was observed in 39.6 % (8.9 %) and 25.8 % (2.95 %) were not tested. Data on a 2(nd) screening were available in a subgroup of women with negative immunity showing less than 45 % participation rate. Active toxoplasmosis (no rubella) infection was observed in 0.3 % (n = 17) of pregnant women. A multiple logistic regression model (AIC = 719.67; AUC = 0.725) revealed that the likelihood of participating in a second toxoplasmosis screening increased among women with a good level of education and a steady partnership and decreased with paternal unemployment and the absence of breastfeeding. The highest probability of non-participation in toxoplasmosis screening was found among women with temporal burden and family responsibilities. A cost-benefit analysis showed that covering general screening for toxoplasmosis with health insurance saved costs.

Conclusion: Toxoplasmosis carried a substantial risk of infection during pregnancy. Although increased socioeconomic status was positively associated with the participation in toxoplasmosis screening, this was not the case when pregnant women had strong temporal burden and family responsibilities. This data supports the need for toxoplasmosis screening among pregnant women as a general healthcare benefit covered by insurance.

Citing Articles

Anti- Antibodies in European Residents: A Systematic Review and Meta-Analysis of Studies Published between 2000 and 2020.

Calero-Bernal R, Gennari S, Cano S, Salas-Fajardo M, Rios A, Alvarez-Garcia G Pathogens. 2023; 12(12).

PMID: 38133313 PMC: 10745778. DOI: 10.3390/pathogens12121430.


Antenatal Screening for Toxoplasmosis and Rubella in Saudi Arabia: Assessing the Need for Screening.

Al-Mughales J, Al-Rabia M J Multidiscip Healthc. 2023; 16:3897-3905.

PMID: 38084119 PMC: 10710800. DOI: 10.2147/JMDH.S438895.


The Importance of Use of the On-line Databases as a Source for Systematic Review of Toxoplasmosis Screening During Pregnancy.

Voyiatzaki C, Orovas C, Trapali M, Chaniotis D, Kriebardis A, Beloukas A Acta Inform Med. 2021; 29(3):216-223.

PMID: 34759463 PMC: 8563042. DOI: 10.5455/aim.2021.29.216-223.


Estimates of Toxoplasmosis Incidence Based on Healthcare Claims Data, Germany, 2011-2016.

Krings A, Jacob J, Seeber F, Pleyer U, Walker J, Stark K Emerg Infect Dis. 2021; 27(8):2097-2106.

PMID: 34286687 PMC: 8314822. DOI: 10.3201/eid2708.203740.


Atypical Bilateral Multifocal Congenital Toxoplasmosis Retinochoroiditis: Case Report With Literature Review.

Reed G, Agarwal-Sinha S J Investig Med High Impact Case Rep. 2020; 8:2324709620961615.

PMID: 33054439 PMC: 7570296. DOI: 10.1177/2324709620961615.


References
1.
Stillwaggon E, Carrier C, Sautter M, McLeod R . Maternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic model. PLoS Negl Trop Dis. 2011; 5(9):e1333. PMC: 3181241. DOI: 10.1371/journal.pntd.0001333. View

2.
Hill D, Dubey J . Toxoplasma gondii: transmission, diagnosis and prevention. Clin Microbiol Infect. 2002; 8(10):634-40. DOI: 10.1046/j.1469-0691.2002.00485.x. View

3.
Elsheikha H . Safer food for pregnant women: practices and risks. Public Health. 2008; 122(12):1407-9. DOI: 10.1016/j.puhe.2008.06.002. View

4.
Hedriana H, Mitchell J, Brown G, Williams S . Normal fetal outcome in a pregnancy with central nervous system toxoplasmosis and human immunodeficiency virus infection. A case report. J Reprod Med. 1993; 38(9):747-50. View

5.
Berrebi A, Bardou M, Bessieres M, Nowakowska D, Castagno R, Rolland M . Outcome for children infected with congenital toxoplasmosis in the first trimester and with normal ultrasound findings: a study of 36 cases. Eur J Obstet Gynecol Reprod Biol. 2006; 135(1):53-7. DOI: 10.1016/j.ejogrb.2006.11.002. View